CONMED Corporation (CNMD)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 64,459 | 57,972 | 88,285 | -93,738 | -80,582 | -82,722 | -113,924 | 67,657 | 62,542 | 62,238 | 54,140 | 13,450 | 9,517 | 310 | 430 | 33,525 | 28,619 | 29,339 | 28,194 | 31,218 |
| Total assets | US$ in thousands | 2,300,020 | 2,325,680 | 2,322,720 | 2,320,120 | 2,297,590 | 2,292,040 | 2,072,260 | 1,785,720 | 1,766,020 | 1,754,090 | 1,761,970 | 1,746,610 | 1,751,670 | 1,743,130 | 1,723,910 | 1,750,970 | 1,775,100 | 1,758,420 | 1,759,400 | 1,760,840 |
| ROA | 2.80% | 2.49% | 3.80% | -4.04% | -3.51% | -3.61% | -5.50% | 3.79% | 3.54% | 3.55% | 3.07% | 0.77% | 0.54% | 0.02% | 0.02% | 1.91% | 1.61% | 1.67% | 1.60% | 1.77% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $64,459K ÷ $2,300,020K
= 2.80%
To analyze Conmed Corp.'s return on assets (ROA) over the past eight quarters, we can observe the following trends:
1. Q4 2023: ROA stands at 2.80%, showing a positive return on assets compared to the previous quarter.
2. Q3 2023: ROA decreased slightly to 2.49%, indicating a dip in the company's ability to generate profits from its assets.
3. Q2 2023: ROA experienced a significant increase to 3.80%, demonstrating improved asset utilization and profitability.
4. Q1 2023: ROA turned negative at -4.04%, suggesting that Conmed Corp. incurred losses relative to its asset base.
5. Q4 2022: ROA was -3.51%, showing a continuation of the negative trend from the previous quarter.
6. Q3 2022: ROA was -3.61%, indicating persistent challenges in asset efficiency and profitability.
7. Q2 2022: ROA recorded the lowest figure at -5.50%, highlighting a substantial decline in profitability and asset utilization.
8. Q1 2022: ROA rebounded to 3.79%, signaling a sharp improvement in the company's ability to generate profits from its assets.
Overall, Conmed Corp.'s ROA has shown volatility and inconsistency over the past eight quarters, with periods of negative returns interspersed with occasional spikes in profitability. It is essential for the company to focus on enhancing operational efficiency and optimizing asset utilization to sustain positive ROA figures in the future.
Peer comparison
Dec 31, 2023